• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2040年预测的由肾功能不全导致的全球非传染性疾病负担

Global burden of non-communicable diseases attributable to kidney dysfunction with projection into 2040.

作者信息

Chen Jing, Li Chunyang, Bu Ci Li Nong, Wang Yujiao, Qi Mei, Fu Ping, Zeng Xiaoxi

机构信息

Division of Nephrology, Kidney Research Institute, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.

West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.

出版信息

Chin Med J (Engl). 2024 May 28. doi: 10.1097/CM9.0000000000003143.

DOI:10.1097/CM9.0000000000003143
PMID:38809055
Abstract

BACKGROUND

Spatiotemporal disparities exist in the disease burden of non-communicable diseases (NCDs) attributable to kidney dysfunction, which has been poorly assessed. The present study aimed to evaluate the spatiotemporal trends of the global burden of NCDs attributable to kidney dysfunction and to predict future trends.

METHODS

Data on NCDs attributable to kidney dysfunction, quantified using deaths and disability-adjusted life-years (DALYs), were extracted from the Global Burden of Diseases Injuries, and Risk Factors (GBD) Study in 2019. Estimated annual percentage change (EAPC) of age-standardized rate (ASR) was calculated with linear regression to assess the changing trend. Pearson's correlation analysis was used to determine the association between ASR and Sociodemographic Index (SDI) for 21 GBD regions. A Bayesian age-period-cohort (BAPC) model was used to predict future trends up to 2040.

RESULTS

Between 1990 and 2019, the absolute number of deaths and DALYs from NCDs attributable to kidney dysfunction increased globally. The death cases increased from 1,571,720 (95% uncertainty interval [UI]: 1,344,420-1,805,598) in 1990 to 3,161,552 (95% UI: 2,723,363-3,623,814) in 2019 for both sexes combined. Both the ASR of death and DALYs increased in Andean Latin America, the Caribbean, Central Latin America, Southeast Asia, Oceania, and Southern Sub-Saharan Africa. In contrast, the age-standardized metrics decreased in the high-income Asia Pacific region. The relationship between SDI and ASR of death and DALYs was negatively correlated. The BAPC model indicated that there would be approximately 5,806,780 death cases and 119,013,659 DALY cases in 2040 that could be attributed to kidney dysfunction. Age-standardized death of cardiovascular diseases (CVDs) and CKD attributable to kidney dysfunction were predicted to decrease and increase from 2020 to 2040, respectively.

CONCLUSION

NCDs attributable to kidney dysfunction remain a major public health concern worldwide. Efforts are required to attenuate the death and disability burden, particularly in low and low-to-middle SDI regions.

摘要

背景

归因于肾功能障碍的非传染性疾病(NCDs)的疾病负担存在时空差异,对此评估不足。本研究旨在评估归因于肾功能障碍的全球非传染性疾病负担的时空趋势,并预测未来趋势。

方法

从《2019年全球疾病、伤害及风险因素负担研究》(Global Burden of Diseases Injuries, and Risk Factors, GBD)中提取了归因于肾功能障碍的非传染性疾病数据,使用死亡人数和伤残调整生命年(DALYs)进行量化。通过线性回归计算年龄标准化率(ASR)的估计年度百分比变化(EAPC),以评估变化趋势。采用Pearson相关分析确定21个GBD区域的ASR与社会人口学指数(SDI)之间的关联。使用贝叶斯年龄-时期-队列(BAPC)模型预测至2040年的未来趋势。

结果

1990年至2019年期间,全球归因于肾功能障碍的非传染性疾病的死亡人数和DALYs绝对值有所增加。1990年,合并两性的死亡病例为1,571,720例(95%不确定区间[UI]:1,344,420 - 1,805,598),到2019年增至3,161,552例(95% UI:2,723,363 - 3,623,814)。安第斯拉丁美洲、加勒比地区、中拉丁美洲、东南亚、大洋洲和撒哈拉以南非洲南部的死亡ASR和DALYs均有所增加。相比之下,高收入亚太地区的年龄标准化指标有所下降。SDI与死亡ASR和DALYs之间呈负相关。BAPC模型表明,到2040年,约有5,806,780例死亡病例和119,013,659例DALY病例可归因于肾功能障碍。预计2020年至2040年期间,归因于肾功能障碍的心血管疾病(CVDs)和慢性肾脏病(CKD)的年龄标准化死亡率将分别下降和上升。

结论

归因于肾功能障碍的非传染性疾病仍然是全球主要的公共卫生问题。需要做出努力以减轻死亡和残疾负担,特别是在低SDI和低至中等SDI地区。

相似文献

1
Global burden of non-communicable diseases attributable to kidney dysfunction with projection into 2040.2040年预测的由肾功能不全导致的全球非传染性疾病负担
Chin Med J (Engl). 2024 May 28. doi: 10.1097/CM9.0000000000003143.
2
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家 84 种行为、环境、职业和代谢风险以及 195 个国家和地区 1990 至 2017 年风险簇的比较风险评估:全球疾病负担研究 2017 系统分析。
Lancet. 2018 Nov 10;392(10159):1923-1994. doi: 10.1016/S0140-6736(18)32225-6. Epub 2018 Nov 8.
3
Burden and attributable risk factors of non-communicable diseases and subtypes in 204 countries and territories, 1990-2021: a systematic analysis for the global burden of disease study 2021.1990 - 2021年204个国家和地区非传染性疾病及其亚型的负担和可归因风险因素:全球疾病负担研究2021的系统分析
Int J Surg. 2025 Mar 1;111(3):2385-2397. doi: 10.1097/JS9.0000000000002260.
4
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.204 个国家和地区 2022-2050 年疾病负担情景:2021 年全球疾病负担研究的预测分析。
Lancet. 2024 May 18;403(10440):2204-2256. doi: 10.1016/S0140-6736(24)00685-8.
5
Global burden, trends, and disparities in kidney cancer attributable to smoking from 1990 to 2021.1990年至2021年因吸烟导致的肾癌的全球负担、趋势及差异
Front Public Health. 2025 Jan 8;12:1506542. doi: 10.3389/fpubh.2024.1506542. eCollection 2024.
6
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家慢性肾脏病负担,1990-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. Epub 2020 Feb 13.
7
Global, regional, and national burden of cardiovascular disease attributable to kidney dysfunction (1990-2021) with projections to 2050: analysis of the 2021 Global Burden of Disease study.1990年至2021年全球、区域和国家层面归因于肾功能不全的心血管疾病负担及到2050年的预测:2021年全球疾病负担研究分析
Ren Fail. 2025 Dec;47(1):2472039. doi: 10.1080/0886022X.2025.2472039. Epub 2025 Feb 27.
8
Burden of non-communicable diseases among adolescents and young adults aged 10-24 years in the South-East Asia and Western Pacific regions, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.1990-2019 年东南亚和西太平洋地区 10-24 岁青少年和青年人群非传染性疾病负担:2019 年全球疾病负担研究的系统分析。
Lancet Child Adolesc Health. 2023 Sep;7(9):621-635. doi: 10.1016/S2352-4642(23)00148-7. Epub 2023 Jul 28.
9
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、地区和国家按年龄、性别划分的 264 种死因的死亡率:2016 年全球疾病负担研究的系统分析。
Lancet. 2017 Sep 16;390(10100):1151-1210. doi: 10.1016/S0140-6736(17)32152-9.
10
The global burden of disease attributable to high body mass index in 195 countries and territories, 1990-2017: An analysis of the Global Burden of Disease Study.2019 年全球 195 个国家和地区因超重导致的疾病负担:基于全球疾病负担研究的分析。
PLoS Med. 2020 Jul 28;17(7):e1003198. doi: 10.1371/journal.pmed.1003198. eCollection 2020 Jul.

引用本文的文献

1
Global burden and risk factors of type 2 diabetes mellitus from 1990 to 2021, with forecasts to 2050.1990年至2021年2型糖尿病的全球负担及风险因素,并预测至2050年。
Front Endocrinol (Lausanne). 2025 Aug 14;16:1538143. doi: 10.3389/fendo.2025.1538143. eCollection 2025.
2
Global, regional, and national burden of multiple myeloma, 1990 to 2021 and predictions to 2035: an analysis of the Global Burden of Disease Study 2021.1990年至2021年全球、区域和国家多发性骨髓瘤负担及2035年预测:全球疾病负担研究2021分析
Front Med (Lausanne). 2025 Jul 31;12:1609692. doi: 10.3389/fmed.2025.1609692. eCollection 2025.
3

本文引用的文献

1
Life's Essential 8 and risk of non-communicable chronic diseases: Outcome-wide analyses.《生命的基础 8 项指标与非传染性慢性疾病风险:全结局分析》
Chin Med J (Engl). 2024 Jul 5;137(13):1553-1562. doi: 10.1097/CM9.0000000000002830. Epub 2023 Oct 10.
2
Disease Burden and Epidemiological Trends of Chronic Kidney Disease at the Global, Regional, National Levels from 1990 to 2019.1990 年至 2019 年全球、区域、国家各级别慢性肾脏病的疾病负担与流行病学趋势。
Nephron. 2024;148(2):113-123. doi: 10.1159/000534071. Epub 2023 Sep 15.
3
The Burden of Rheumatoid Arthritis: Findings from the 2019 Global Burden of Diseases Study and Forecasts for 2030 by Bayesian Age-Period-Cohort Analysis.
Trends and regional disparities in maternal hypertensive disorders among women of childbearing age: a global burden of disease analysis from 1990 to 2021.
育龄妇女孕产妇高血压疾病的趋势及地区差异:1990年至2021年全球疾病负担分析
BMC Pregnancy Childbirth. 2025 Aug 6;25(1):812. doi: 10.1186/s12884-025-07926-0.
4
Global burden of major chronic respiratory diseases among older adults aged 55 and above from 1990 to 2021: Changes, challenges, and predictions amid the pandemic.1990年至2021年55岁及以上老年人主要慢性呼吸道疾病的全球负担:大流行期间的变化、挑战及预测
PLoS One. 2025 Aug 1;20(8):e0329283. doi: 10.1371/journal.pone.0329283. eCollection 2025.
5
Global, regional and national burden of blindness and vision loss attributable to diabetic retinopathy, 1990-2021: A systematic analysis for the Global Burden of Disease Study 2021.1990年至2021年全球、区域和国家层面糖尿病性视网膜病变所致失明和视力丧失负担:全球疾病负担研究2021的系统分析
Diabetes Obes Metab. 2025 Oct;27(10):5464-5477. doi: 10.1111/dom.16588. Epub 2025 Jul 22.
6
The global burden of aortic aneurysm attributable to hypertension from 1990 to 2021: Current trends and projections for 2050.1990年至2021年高血压所致主动脉瘤的全球负担:当前趋势及2050年预测
PLoS One. 2025 Jul 18;20(7):e0327830. doi: 10.1371/journal.pone.0327830. eCollection 2025.
7
Social Isolation Is Associated With the Acceleration of Death and Incident Cardiovascular Disease in Adults With Chronic Kidney Disease.社交隔离与慢性肾脏病成人患者的死亡加速和心血管疾病发病有关。
J Am Heart Assoc. 2025 Jun 3;14(11):e038951. doi: 10.1161/JAHA.124.038951. Epub 2025 May 22.
8
Burden of Skin Cancer in Older Adults From 1990 to 2021 and Modelled Projection to 2050.1990年至2021年老年人皮肤癌负担及至2050年的模拟预测
JAMA Dermatol. 2025 May 21. doi: 10.1001/jamadermatol.2025.1276.
9
Global, regional, and national burden of cardiovascular disease attributable to high body mass index from 1990 to 2021 and projection to 2045.1990年至2021年以及到2045年预测期间,因高体重指数所致心血管疾病的全球、区域和国家负担
Front Endocrinol (Lausanne). 2025 Apr 28;16:1546176. doi: 10.3389/fendo.2025.1546176. eCollection 2025.
10
Natural products in traditional Chinese medicine for renal fibrosis: a comprehensive review.用于肾纤维化的中药天然产物:综述
Front Pharmacol. 2025 Apr 16;16:1560567. doi: 10.3389/fphar.2025.1560567. eCollection 2025.
类风湿关节炎的负担:2019年全球疾病负担研究结果及基于贝叶斯年龄-时期-队列分析的2030年预测
J Clin Med. 2023 Feb 6;12(4):1291. doi: 10.3390/jcm12041291.
4
Climate change-fuelled natural disasters and chronic kidney disease: a call for action.气候变化引发的自然灾害与慢性肾脏病:行动呼吁
Nat Rev Nephrol. 2023 Mar;19(3):141-142. doi: 10.1038/s41581-023-00682-4.
5
Healthy aging and chronic kidney disease.健康老龄化与慢性肾脏病
Kidney Res Clin Pract. 2022 Nov;41(6):644-656. doi: 10.23876/j.krcp.22.112. Epub 2022 Oct 25.
6
Global disease burden of COPD from 1990 to 2019 and prediction of future disease burden trend in China.中国 COPD 疾病负担的全球变化:1990 年至 2019 年以及未来疾病负担趋势的预测。
Public Health. 2022 Jul;208:89-97. doi: 10.1016/j.puhe.2022.04.015. Epub 2022 Jun 18.
7
Impact of high, low, and non-optimum temperatures on chronic kidney disease in a changing climate, 1990-2019: A global analysis.气候变化下高、低温和不适宜温度对慢性肾脏病的影响:1990-2019 年全球分析。
Environ Res. 2022 Sep;212(Pt A):113172. doi: 10.1016/j.envres.2022.113172. Epub 2022 Mar 25.
8
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 87 种风险因素的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1223-1249. doi: 10.1016/S0140-6736(20)30752-2.
9
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
10
Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1950-2019 年全球年龄性别特定生育率、死亡率、健康期望寿命(HALE)和人口估计值:2019 年全球疾病负担研究的综合人口分析。
Lancet. 2020 Oct 17;396(10258):1160-1203. doi: 10.1016/S0140-6736(20)30977-6.